FDA Approves OncoSil Device for Distal Cholangiocarcinoma
FDA Approves OncoSil Device for Distal Cholangiocarcinoma Oncodaily
Finance, IT & News
FDA Approves OncoSil Device for Distal Cholangiocarcinoma Oncodaily
Takeda Pharmaceutical (TSE:4502) Wins FDA Approval For ORZEYFUL, Is The Stock Still Cheap? simplywall.st
Fitch Upgrades IIFL Finance to BB-; Outlook Stable The Tribune
FDA Clears Cortechs.ai's NeuroQuant PET Imaging Technology News
FDA clears Wellvii's finger-based blood pressure monitor for home use Medical Economics